Author:
Jacobsen Jacob PR,Rudder Meghan L,Roberts Wendy,Royer Elizabeth L,Robinson Taylor J,Oh Adrianna,Spasojevic Ivan,Sachs Benjamin D,Caron Marc G
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference54 articles.
1. Aan Het Rot M, Zarate CA Jr, Charney DS, Mathew SJ (2012). Ketamine for depression: where do we go from here? Biol Psychiatry 72: 537–547.
2. Baumann P, Ulrich S, Eckermann G, Gerlach M, Kuss HJ, Laux G et al (2005). The AGNP-TDM Expert Group Consensus Guidelines: focus on therapeutic monitoring of antidepressants. Dialogues Clin Neurosci 7: 231–247.
3. Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC et al (2008). Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105: 1333–1338.
4. Bender DA (1983). Biochemistry of tryptophan in health and disease. Mol Aspects Med 6: 101–197.
5. Benton CS, Miller BH, Skwerer S, Suzuki O, Schultz LE, Cameron MD et al (2012). Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology 221: 297–315.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献